Global Oral Anti-HBV Drugs Market Research Report 2026

1 Oral Anti-HBV Drugs Market Overview
1.1 Product Definition
1.2 Oral Anti-HBV Drugs by Type
1.2.1 Global Oral Anti-HBV Drugs Market Value by Type: 2025 vs 2032
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 Telbivudine
1.2.5 Lamivudine
1.2.6 Adefovir
1.2.7 Other
1.3 Oral Anti-HBV Drugs by Application
1.3.1 Global Oral Anti-HBV Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Anti-HBV Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Anti-HBV Drugs Revenue 2021–2032
1.4.2 Global Oral Anti-HBV Drugs Sales 2021–2032
1.4.3 Global Oral Anti-HBV Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Oral Anti-HBV Drugs Market Competition by Manufacturers
2.1 Global Oral Anti-HBV Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Oral Anti-HBV Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Oral Anti-HBV Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Oral Anti-HBV Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Oral Anti-HBV Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Oral Anti-HBV Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Oral Anti-HBV Drugs, Date of Entry into the Industry
2.8 Global Oral Anti-HBV Drugs Market Competitive Situation and Trends
2.8.1 Global Oral Anti-HBV Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Oral Anti-HBV Drugs Players Market Share by Revenue
2.8.3 Global Oral Anti-HBV Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Anti-HBV Drugs Market Scenario by Region
3.1 Global Oral Anti-HBV Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Oral Anti-HBV Drugs Sales by Region: 2021–2032
3.2.1 Global Oral Anti-HBV Drugs Sales by Region: 2021–2026
3.2.2 Global Oral Anti-HBV Drugs Sales by Region: 2027–2032
3.3 Global Oral Anti-HBV Drugs Revenue by Region: 2021–2032
3.3.1 Global Oral Anti-HBV Drugs Revenue by Region: 2021–2026
3.3.2 Global Oral Anti-HBV Drugs Revenue by Region: 2027–2032
3.4 North America Oral Anti-HBV Drugs Market Facts & Figures by Country
3.4.1 North America Oral Anti-HBV Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Oral Anti-HBV Drugs Sales by Country (2021–2032)
3.4.3 North America Oral Anti-HBV Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Anti-HBV Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Anti-HBV Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Oral Anti-HBV Drugs Sales by Country (2021–2032)
3.5.3 Europe Oral Anti-HBV Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Anti-HBV Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Anti-HBV Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Oral Anti-HBV Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Oral Anti-HBV Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Anti-HBV Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Anti-HBV Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Oral Anti-HBV Drugs Sales by Country (2021–2032)
3.7.3 Latin America Oral Anti-HBV Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Anti-HBV Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Anti-HBV Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Oral Anti-HBV Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Oral Anti-HBV Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Anti-HBV Drugs Sales by Type (2021–2032)
4.1.1 Global Oral Anti-HBV Drugs Sales by Type (2021–2026)
4.1.2 Global Oral Anti-HBV Drugs Sales by Type (2027–2032)
4.1.3 Global Oral Anti-HBV Drugs Sales Market Share by Type (2021–2032)
4.2 Global Oral Anti-HBV Drugs Revenue by Type (2021–2032)
4.2.1 Global Oral Anti-HBV Drugs Revenue by Type (2021–2026)
4.2.2 Global Oral Anti-HBV Drugs Revenue by Type (2027–2032)
4.2.3 Global Oral Anti-HBV Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Oral Anti-HBV Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Oral Anti-HBV Drugs Sales by Application (2021–2032)
5.1.1 Global Oral Anti-HBV Drugs Sales by Application (2021–2026)
5.1.2 Global Oral Anti-HBV Drugs Sales by Application (2027–2032)
5.1.3 Global Oral Anti-HBV Drugs Sales Market Share by Application (2021–2032)
5.2 Global Oral Anti-HBV Drugs Revenue by Application (2021–2032)
5.2.1 Global Oral Anti-HBV Drugs Revenue by Application (2021–2026)
5.2.2 Global Oral Anti-HBV Drugs Revenue by Application (2027–2032)
5.2.3 Global Oral Anti-HBV Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Oral Anti-HBV Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bristol Myers Squibb Oral Anti-HBV Drugs Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Gilead Sciences Oral Anti-HBV Drugs Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Viatris Oral Anti-HBV Drugs Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Sigmapharm Laboratories
6.4.1 Sigmapharm Laboratories Company Information
6.4.2 Sigmapharm Laboratories Description and Business Overview
6.4.3 Sigmapharm Laboratories Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sigmapharm Laboratories Oral Anti-HBV Drugs Product Portfolio
6.4.5 Sigmapharm Laboratories Recent Developments/Updates
6.5 Sandoz Pharmaceuticals
6.5.1 Sandoz Pharmaceuticals Company Information
6.5.2 Sandoz Pharmaceuticals Description and Business Overview
6.5.3 Sandoz Pharmaceuticals Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sandoz Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio
6.5.5 Sandoz Pharmaceuticals Recent Developments/Updates
6.6 Camber Pharmaceuticals
6.6.1 Camber Pharmaceuticals Company Information
6.6.2 Camber Pharmaceuticals Description and Business Overview
6.6.3 Camber Pharmaceuticals Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Camber Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio
6.6.5 Camber Pharmaceuticals Recent Developments/Updates
6.7 Towa Pharmaceutical
6.7.1 Towa Pharmaceutical Company Information
6.7.2 Towa Pharmaceutical Description and Business Overview
6.7.3 Towa Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Towa Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.7.5 Towa Pharmaceutical Recent Developments/Updates
6.8 GSK
6.8.1 GSK Company Information
6.8.2 GSK Description and Business Overview
6.8.3 GSK Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 GSK Oral Anti-HBV Drugs Product Portfolio
6.8.5 GSK Recent Developments/Updates
6.9 Teva
6.9.1 Teva Company Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Teva Oral Anti-HBV Drugs Product Portfolio
6.9.5 Teva Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Apotex Oral Anti-HBV Drugs Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Chia Tai Tianqing Pharmaceutical
6.11.1 Chia Tai Tianqing Pharmaceutical Company Information
6.11.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.11.3 Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.11.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.12 Beijing Baiao Pharmaceutical
6.12.1 Beijing Baiao Pharmaceutical Company Information
6.12.2 Beijing Baiao Pharmaceutical Description and Business Overview
6.12.3 Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.12.5 Beijing Baiao Pharmaceutical Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Company Information
6.13.2 Qilu Pharmaceutical Description and Business Overview
6.13.3 Qilu Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Qilu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
6.14 Fujian Cosunter pharmaceutical
6.14.1 Fujian Cosunter pharmaceutical Company Information
6.14.2 Fujian Cosunter pharmaceutical Description and Business Overview
6.14.3 Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.14.5 Fujian Cosunter pharmaceutical Recent Developments/Updates
6.15 YaoPharma
6.15.1 YaoPharma Company Information
6.15.2 YaoPharma Description and Business Overview
6.15.3 YaoPharma Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 YaoPharma Oral Anti-HBV Drugs Product Portfolio
6.15.5 YaoPharma Recent Developments/Updates
6.16 Jiangxi Qingfeng Pharmaceutical
6.16.1 Jiangxi Qingfeng Pharmaceutical Company Information
6.16.2 Jiangxi Qingfeng Pharmaceutical Description and Business Overview
6.16.3 Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.16.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
6.17 Easton Biopharmaceuticals
6.17.1 Easton Biopharmaceuticals Company Information
6.17.2 Easton Biopharmaceuticals Description and Business Overview
6.17.3 Easton Biopharmaceuticals Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Easton Biopharmaceuticals Oral Anti-HBV Drugs Product Portfolio
6.17.5 Easton Biopharmaceuticals Recent Developments/Updates
6.18 Chengdu Brilliant Pharmaceutical
6.18.1 Chengdu Brilliant Pharmaceutical Company Information
6.18.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.18.3 Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.18.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.19 Sichuan Kelun Pharmaceutical
6.19.1 Sichuan Kelun Pharmaceutical Company Information
6.19.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.19.3 Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.19.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.20 Anhui Biochem
6.20.1 Anhui Biochem Company Information
6.20.2 Anhui Biochem Description and Business Overview
6.20.3 Anhui Biochem Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Anhui Biochem Oral Anti-HBV Drugs Product Portfolio
6.20.5 Anhui Biochem Recent Developments/Updates
6.21 Qianjin Pharmaceutical
6.21.1 Qianjin Pharmaceutical Company Information
6.21.2 Qianjin Pharmaceutical Description and Business Overview
6.21.3 Qianjin Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Qianjin Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.21.5 Qianjin Pharmaceutical Recent Developments/Updates
6.22 Shanghai Desano Pharmaceutical
6.22.1 Shanghai Desano Pharmaceutical Company Information
6.22.2 Shanghai Desano Pharmaceutical Description and Business Overview
6.22.3 Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.22.5 Shanghai Desano Pharmaceutical Recent Developments/Updates
6.23 Zhongfu Pharmaceutical
6.23.1 Zhongfu Pharmaceutical Company Information
6.23.2 Zhongfu Pharmaceutical Description and Business Overview
6.23.3 Zhongfu Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Zhongfu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.23.5 Zhongfu Pharmaceutical Recent Developments/Updates
6.24 Tianjin Yaowu Academe Pharmaceutical Industry
6.24.1 Tianjin Yaowu Academe Pharmaceutical Industry Company Information
6.24.2 Tianjin Yaowu Academe Pharmaceutical Industry Description and Business Overview
6.24.3 Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Product Portfolio
6.24.5 Tianjin Yaowu Academe Pharmaceutical Industry Recent Developments/Updates
6.25 Beijing SL Pharmaceutical
6.25.1 Beijing SL Pharmaceutical Company Information
6.25.2 Beijing SL Pharmaceutical Description and Business Overview
6.25.3 Beijing SL Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Beijing SL Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.25.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.26 Cisen Pharmaceutical
6.26.1 Cisen Pharmaceutical Company Information
6.26.2 Cisen Pharmaceutical Description and Business Overview
6.26.3 Cisen Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Cisen Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
6.26.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Anti-HBV Drugs Industry Chain Analysis
7.2 Oral Anti-HBV Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Anti-HBV Drugs Production Mode & Process Analysis
7.4 Oral Anti-HBV Drugs Sales and Marketing
7.4.1 Oral Anti-HBV Drugs Sales Channels
7.4.2 Oral Anti-HBV Drugs Distributors
7.5 Oral Anti-HBV Drugs Customer Analysis
8 Oral Anti-HBV Drugs Market Dynamics
8.1 Oral Anti-HBV Drugs Industry Trends
8.2 Oral Anti-HBV Drugs Market Drivers
8.3 Oral Anti-HBV Drugs Market Challenges
8.4 Oral Anti-HBV Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Oral Anti-HBV Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Anti-HBV Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Anti-HBV Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Anti-HBV Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Anti-HBV Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Anti-HBV Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Anti-HBV Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Anti-HBV Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Anti-HBV Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Anti-HBV Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Anti-HBV Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Anti-HBV Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Anti-HBV Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Anti-HBV Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Anti-HBV Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Anti-HBV Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Oral Anti-HBV Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Oral Anti-HBV Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Oral Anti-HBV Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Oral Anti-HBV Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Anti-HBV Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Anti-HBV Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Anti-HBV Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Anti-HBV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Anti-HBV Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Oral Anti-HBV Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Anti-HBV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Anti-HBV Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Anti-HBV Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Anti-HBV Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Anti-HBV Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Anti-HBV Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Anti-HBV Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Anti-HBV Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Anti-HBV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Anti-HBV Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Anti-HBV Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Anti-HBV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Anti-HBV Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Anti-HBV Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Anti-HBV Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Anti-HBV Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Anti-HBV Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Anti-HBV Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Oral Anti-HBV Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Oral Anti-HBV Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Anti-HBV Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Anti-HBV Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Anti-HBV Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Anti-HBV Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Anti-HBV Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Anti-HBV Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Anti-HBV Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Anti-HBV Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Oral Anti-HBV Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Oral Anti-HBV Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Anti-HBV Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Anti-HBV Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Anti-HBV Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Anti-HBV Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Anti-HBV Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bristol Myers Squibb Oral Anti-HBV Drugs Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Gilead Sciences Oral Anti-HBV Drugs Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Viatris Company Information
Table 81. Viatris Description and Business Overview
Table 82. Viatris Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Viatris Oral Anti-HBV Drugs Product
Table 84. Viatris Recent Developments/Updates
Table 85. Sigmapharm Laboratories Company Information
Table 86. Sigmapharm Laboratories Description and Business Overview
Table 87. Sigmapharm Laboratories Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sigmapharm Laboratories Oral Anti-HBV Drugs Product
Table 89. Sigmapharm Laboratories Recent Developments/Updates
Table 90. Sandoz Pharmaceuticals Company Information
Table 91. Sandoz Pharmaceuticals Description and Business Overview
Table 92. Sandoz Pharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sandoz Pharmaceuticals Oral Anti-HBV Drugs Product
Table 94. Sandoz Pharmaceuticals Recent Developments/Updates
Table 95. Camber Pharmaceuticals Company Information
Table 96. Camber Pharmaceuticals Description and Business Overview
Table 97. Camber Pharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Camber Pharmaceuticals Oral Anti-HBV Drugs Product
Table 99. Camber Pharmaceuticals Recent Developments/Updates
Table 100. Towa Pharmaceutical Company Information
Table 101. Towa Pharmaceutical Description and Business Overview
Table 102. Towa Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Towa Pharmaceutical Oral Anti-HBV Drugs Product
Table 104. Towa Pharmaceutical Recent Developments/Updates
Table 105. GSK Company Information
Table 106. GSK Description and Business Overview
Table 107. GSK Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. GSK Oral Anti-HBV Drugs Product
Table 109. GSK Recent Developments/Updates
Table 110. Teva Company Information
Table 111. Teva Description and Business Overview
Table 112. Teva Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Teva Oral Anti-HBV Drugs Product
Table 114. Teva Recent Developments/Updates
Table 115. Apotex Company Information
Table 116. Apotex Description and Business Overview
Table 117. Apotex Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Apotex Oral Anti-HBV Drugs Product
Table 119. Apotex Recent Developments/Updates
Table 120. Chia Tai Tianqing Pharmaceutical Company Information
Table 121. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 122. Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Product
Table 124. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 125. Beijing Baiao Pharmaceutical Company Information
Table 126. Beijing Baiao Pharmaceutical Description and Business Overview
Table 127. Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Product
Table 129. Beijing Baiao Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Qilu Pharmaceutical Oral Anti-HBV Drugs Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. Fujian Cosunter pharmaceutical Company Information
Table 136. Fujian Cosunter pharmaceutical Description and Business Overview
Table 137. Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Product
Table 139. Fujian Cosunter pharmaceutical Recent Developments/Updates
Table 140. YaoPharma Company Information
Table 141. YaoPharma Description and Business Overview
Table 142. YaoPharma Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. YaoPharma Oral Anti-HBV Drugs Product
Table 144. YaoPharma Recent Developments/Updates
Table 145. Jiangxi Qingfeng Pharmaceutical Company Information
Table 146. Jiangxi Qingfeng Pharmaceutical Description and Business Overview
Table 147. Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Product
Table 149. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 150. Easton Biopharmaceuticals Company Information
Table 151. Easton Biopharmaceuticals Description and Business Overview
Table 152. Easton Biopharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Easton Biopharmaceuticals Oral Anti-HBV Drugs Product
Table 154. Easton Biopharmaceuticals Recent Developments/Updates
Table 155. Chengdu Brilliant Pharmaceutical Company Information
Table 156. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 157. Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Product
Table 159. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 160. Sichuan Kelun Pharmaceutical Company Information
Table 161. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 162. Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Product
Table 164. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 165. Anhui Biochem Company Information
Table 166. Anhui Biochem Description and Business Overview
Table 167. Anhui Biochem Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Anhui Biochem Oral Anti-HBV Drugs Product
Table 169. Anhui Biochem Recent Developments/Updates
Table 170. Qianjin Pharmaceutical Company Information
Table 171. Qianjin Pharmaceutical Description and Business Overview
Table 172. Qianjin Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Qianjin Pharmaceutical Oral Anti-HBV Drugs Product
Table 174. Qianjin Pharmaceutical Recent Developments/Updates
Table 175. Shanghai Desano Pharmaceutical Company Information
Table 176. Shanghai Desano Pharmaceutical Description and Business Overview
Table 177. Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Product
Table 179. Shanghai Desano Pharmaceutical Recent Developments/Updates
Table 180. Zhongfu Pharmaceutical Company Information
Table 181. Zhongfu Pharmaceutical Description and Business Overview
Table 182. Zhongfu Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Zhongfu Pharmaceutical Oral Anti-HBV Drugs Product
Table 184. Zhongfu Pharmaceutical Recent Developments/Updates
Table 185. Tianjin Yaowu Academe Pharmaceutical Industry Company Information
Table 186. Tianjin Yaowu Academe Pharmaceutical Industry Description and Business Overview
Table 187. Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Product
Table 189. Tianjin Yaowu Academe Pharmaceutical Industry Recent Developments/Updates
Table 190. Beijing SL Pharmaceutical Company Information
Table 191. Beijing SL Pharmaceutical Description and Business Overview
Table 192. Beijing SL Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Beijing SL Pharmaceutical Oral Anti-HBV Drugs Product
Table 194. Beijing SL Pharmaceutical Recent Developments/Updates
Table 195. Cisen Pharmaceutical Company Information
Table 196. Cisen Pharmaceutical Description and Business Overview
Table 197. Cisen Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 198. Cisen Pharmaceutical Oral Anti-HBV Drugs Product
Table 199. Cisen Pharmaceutical Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Oral Anti-HBV Drugs Distributors List
Table 203. Oral Anti-HBV Drugs Customers List
Table 204. Oral Anti-HBV Drugs Market Trends
Table 205. Oral Anti-HBV Drugs Market Drivers
Table 206. Oral Anti-HBV Drugs Market Challenges
Table 207. Oral Anti-HBV Drugs Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report


List of Figures
Figure 1. Product Picture of Oral Anti-HBV Drugs
Figure 2. Global Oral Anti-HBV Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Anti-HBV Drugs Market Share by Type: 2025 & 2032
Figure 4. Entecavir Product Picture
Figure 5. Tenofovir Product Picture
Figure 6. Telbivudine Product Picture
Figure 7. Lamivudine Product Picture
Figure 8. Adefovir Product Picture
Figure 9. Other Product Picture
Figure 10. Global Oral Anti-HBV Drugs Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Oral Anti-HBV Drugs Market Share by Application: 2025 & 2032
Figure 12. Hospital and Clinic
Figure 13. Pharmacy
Figure 14. Other
Figure 15. Global Oral Anti-HBV Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Oral Anti-HBV Drugs Market Size (US$ Million), 2021–2032
Figure 17. Global Oral Anti-HBV Drugs Sales (K Units), 2021–2032
Figure 18. Global Oral Anti-HBV Drugs Average Price (US$/Unit), 2021–2032
Figure 19. Oral Anti-HBV Drugs Report Years Considered
Figure 20. Oral Anti-HBV Drugs Sales Share by Manufacturers in 2025
Figure 21. Global Oral Anti-HBV Drugs Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Oral Anti-HBV Drugs Players: Market Share by Revenue in Oral Anti-HBV Drugs in 2025
Figure 23. Oral Anti-HBV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Oral Anti-HBV Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Oral Anti-HBV Drugs Sales Market Share by Country (2021–2032)
Figure 26. North America Oral Anti-HBV Drugs Revenue Market Share by Country (2021–2032)
Figure 27. United States Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Oral Anti-HBV Drugs Sales Market Share by Country (2021–2032)
Figure 30. Europe Oral Anti-HBV Drugs Revenue Market Share by Country (2021–2032)
Figure 31. Germany Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Oral Anti-HBV Drugs Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Oral Anti-HBV Drugs Revenue Market Share by Region (2021–2032)
Figure 38. China Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Oral Anti-HBV Drugs Sales Market Share by Country (2021–2032)
Figure 46. Latin America Oral Anti-HBV Drugs Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Oral Anti-HBV Drugs Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Oral Anti-HBV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Oral Anti-HBV Drugs by Type (2021–2032)
Figure 57. Global Revenue Market Share of Oral Anti-HBV Drugs by Type (2021–2032)
Figure 58. Global Oral Anti-HBV Drugs Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Oral Anti-HBV Drugs by Application (2021–2032)
Figure 60. Global Revenue Market Share of Oral Anti-HBV Drugs by Application (2021–2032)
Figure 61. Global Oral Anti-HBV Drugs Price (US$/Unit) by Application (2021–2032)
Figure 62. Oral Anti-HBV Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit